Although not fully deterministic for the development of cancer, certain genes – such as the BRCA1 gene, are well known to be implicated and to significantly raise a person’s cancer risk. Why is it then, that we have not heard more about CRISPR-Cas9 being developed for cancer therapies?READ MORE
Professor Adrian Martineau at Queen Mary University of London is the lead researcher on the CORONAVIT trial that is exploring the effectiveness of correcting vitamin D deficiency in reducing the risk of developing COVID-19. In this interview, we ask Martineau about the rationale behind this study, what impact the UK COVID-19 vaccine rollout may have on the power of the trial and the potential impact of the results.READ MORE
Scientists have used supercomputers to discover new frontiers in science and to invent new technologies to improve the human condition. Now, researchers are using supercomputing resources to address one of society’s biggest challenges – the risks of an unregulated drug market.READ MORE
Research conducted by Uppsala University researchers demonstrates that the use of oral contraceptives may protect women against ovarian and endometrial cancers. The observational study, published in the journal Cancer Research, included analysis of 256,661 women.READ MORE
The pandemic has forever changed how every healthcare stakeholder approaches disease and put a global spotlight on the importance of health and wellness. These forces create a perfect storm for making 2021 a critical year for precision health, when we will bring about new strategies to tackle illness through asymptomatic testing and early detection.
Drug repurposing (also known as drug repositioning) is a strategy for discovering new uses for approved and investigational drugs that are beyond the scope of the original medical indication. In this article, we highlight some benefits related to the repositioning of drugs and provide some examples of areas exploiting this approach.READ MORE